CIBRN Poll: With the expanding number of options available for treating specific conditions, is there merit in limiting choice by using a stratified or step approach to selection?

If you haven’t yet participated in the poll, we invite you to share your views:

With the expanding number of options available for treating specific conditions, is there merit in limiting choice by using a stratified or step approach to selection?

  • Yes, stratification should be used with the more costly biologic therapies.
  • Yes, stratification should be used for all classical and biologic therapies.
  • No, physicians and patients should be free to select any biologic therapy after failing traditional classical therapies.
  • No, physicians and patients should be free to select any classical or biologic therapy in any order once systemic therapy is indicated.

Click here to answer